TC
EHC icon

Trilogy Capital’s Encompass Health EHC Stock Holding History

Trilogy Capital’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,520
Closed -$235K – 305
2023
Q4 		$235K Sell
3,520
-706
-17% -$45.7K 0.01% 241
2023
Q3 		$284K Sell
4,226
-851
-17% -$58.5K 0.02% 201
2023
Q2 		$338K Sell
5,077
-431
-8% -$27K 0.02% 210
2023
Q1 		$298K Buy
5,508
+453
+9% +$26.4K 0.02% 216
2022
Q4 		$302K Buy
+5,055
New +$275K 0.02% 201
2019
Q1 		– Sell
-6,563
Closed -$322K – 132
2018
Q4 		$322K Sell
6,563
-1,726
-21% -$98.2K 0.04% 103
2018
Q3 		$514K Sell
8,289
-1,766
-18% -$107K 0.06% 92
2018
Q2 		$542K Sell
10,055
-1,523
-13% -$76.1K 0.07% 76
2018
Q1 		$527K Buy
+11,578
New +$496K 0.08% 74

Other funds holding EHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Trilogy Capital's EHC Position: Q1 2024 in Review

Trilogy Capital sold out of Encompass Health (EHC) in Q1 2024, closing a stake of 3,520 shares — an estimated $235K sold.

Trilogy Capital first reported a position in EHC in Q1 2018 and held it in 9 quarters. The position peaked at $542K in Q2 2018. 437 funds tracked by Wall St. Rank hold EHC as of Q1 2024.

  • Trilogy Capital reported no remaining Encompass Health position as of Q1 2024 after selling out during the quarter.
  • Trilogy Capital sold 3,520 Encompass Health shares in Q1 2024, an estimated $235K.
  • Trilogy Capital first reported a position in Encompass Health in Q1 2018 and held it in 9 quarters.
  • Trilogy Capital's Encompass Health position peaked at $542K in Q2 2018.
  • 437 funds tracked by Wall St. Rank held Encompass Health as of Q1 2024.

Based on Trilogy Capital's 13F filing for Q1 2024, filed 17 Apr 2024.